Humanwell Healthcare (Group) Co.,Ltd.

SHSE:600079 Stock Report

Market Cap: CN¥25.9b

Humanwell Healthcare (Group)Ltd Future Growth

Future criteria checks 1/6

Humanwell Healthcare (Group)Ltd is forecast to grow earnings and revenue by 19.6% and 6.9% per annum respectively. EPS is expected to grow by 19.5% per annum. Return on equity is forecast to be 12.4% in 3 years.

Key information

19.6%

Earnings growth rate

19.5%

EPS growth rate

Pharmaceuticals earnings growth19.2%
Revenue growth rate6.9%
Future return on equity12.4%
Analyst coverage

Low

Last updated01 Aug 2024

Recent future growth updates

Recent updates

There's No Escaping Humanwell Healthcare (Group) Co.,Ltd.'s (SHSE:600079) Muted Earnings Despite A 26% Share Price Rise

Aug 04
There's No Escaping Humanwell Healthcare (Group) Co.,Ltd.'s (SHSE:600079) Muted Earnings Despite A 26% Share Price Rise

Humanwell Healthcare (Group) Co.,Ltd.'s (SHSE:600079) Low P/E No Reason For Excitement

May 22
Humanwell Healthcare (Group) Co.,Ltd.'s (SHSE:600079) Low P/E No Reason For Excitement

Earnings and Revenue Growth Forecasts

SHSE:600079 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202629,9063,166N/A3,7043
12/31/202528,0682,739N/A3,4523
12/31/202426,4722,258N/A3,3433
6/30/202425,0031,9228092,428N/A
3/31/202424,6661,9564282,306N/A
12/31/202324,5252,13491,967N/A
9/30/202324,1942,0286152,545N/A
6/30/202324,1422,3057612,495N/A
3/31/202323,3792,2353441,959N/A
12/31/202222,3382,484-6722,441N/A
9/30/202221,9432,448-9702,225N/A
6/30/202221,4592,158-1,0592,140N/A
3/31/202221,0631,931-9642,272N/A
12/31/202120,5491,3174762,179N/A
9/30/202120,3841,6303261,816N/A
6/30/202120,6941,2768522,259N/A
3/31/202120,4651,3137031,937N/A
12/31/202020,6801,0069922,090N/A
9/30/202020,5497101,1282,024N/A
6/30/202020,9408981,0181,721N/A
3/31/202021,1198061,1581,911N/A
12/31/201921,8078431,2282,038N/A
9/30/201921,200-2,2619581,958N/A
6/30/201920,317-2,5232381,473N/A
3/31/201919,459-2,362-971,133N/A
12/31/201818,634-2,358-714603N/A
9/30/201818,299778-1,711-256N/A
6/30/201817,4222,195-1,638-196N/A
3/31/201816,5542,049N/A-60N/A
12/31/201715,4462,069N/A93N/A
9/30/201714,2402,149N/A193N/A
6/30/201713,478781N/A170N/A
3/31/201712,979881N/A159N/A
12/31/201612,331832N/A526N/A
9/30/201611,898836N/A597N/A
6/30/201611,294781N/A498N/A
3/31/201610,602668N/A141N/A
12/31/201510,054654N/A311N/A
9/30/20158,941565N/A96N/A
6/30/20158,213523N/A191N/A
3/31/20157,579494N/A556N/A
12/31/20147,052452N/A503N/A
9/30/20146,754435N/A887N/A
6/30/20146,518440N/A901N/A
3/31/20146,239425N/A747N/A
12/31/20136,010418N/A498N/A
9/30/20136,062389N/A203N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600079's forecast earnings growth (19.6% per year) is above the savings rate (2.9%).

Earnings vs Market: 600079's earnings (19.6% per year) are forecast to grow slower than the CN market (23.1% per year).

High Growth Earnings: 600079's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600079's revenue (6.9% per year) is forecast to grow slower than the CN market (13.2% per year).

High Growth Revenue: 600079's revenue (6.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600079's Return on Equity is forecast to be low in 3 years time (12.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y